Clinical Trial Update: Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil Daily [Phase 3]

View source ↗

Summary

Phase 3 trial results for daily tadalafil in patients with signs and symptoms of benign prostatic hyperplasia were posted after the study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Cialis (tadalafil)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Benign Prostatic Hyperplasia | Phase 3 | Status: COMPLETED | Results posted: 2010-11-17